What are the side effects of Linzess (linaclotide) and how long does it take to work?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Linzess Side Effects and Time to Work

Diarrhea is the most common side effect of Linzess (linaclotide), typically beginning within the first 2 weeks of treatment, and the medication generally starts working within the first week with sustained effects throughout treatment.

Time to Effectiveness

Linzess demonstrates a rapid onset of action. Based on the FDA label and clinical trial data, patients typically experience:

  • First bowel movement: Within approximately 24 hours (mean 23.6 hours in clinical trials) 1, 2
  • Symptom improvement: Effects are observed within the first week of treatment and are sustained throughout the 12-week treatment period 3
  • Peak benefit: Most patients who respond see improvements in both bowel habits and abdominal symptoms by week 2 4

The medication works by increasing intestinal fluid secretion and accelerating gastrointestinal transit through guanylate cyclase-C receptor activation 5.

Side Effects Profile

Most Common Side Effects

Diarrhea is by far the most frequent adverse reaction 1:

  • Occurs in 16-22% of patients taking the 145 mcg dose (vs. 5-7% with placebo)
  • Typically starts within the first 2 weeks of treatment 1
  • Usually mild to moderate in severity
  • Leads to discontinuation in only 3-5% of patients 5
  • Severe diarrhea occurs in less than 2% of patients 1

Other Common Side Effects (occurring in ≥2% of patients) 1:

  • Abdominal pain (7%)
  • Flatulence (6%)
  • Abdominal distension/bloating (3%)
  • Upper respiratory tract infection (5%)
  • Sinusitis (3%)

Less Common Side Effects (<2% but more than placebo) 1:

  • Defecation urgency
  • Fecal incontinence
  • Dyspepsia
  • Viral gastroenteritis
  • Nausea

Serious but Rare Side Effects (Post-marketing) 1:

  • Hypersensitivity reactions (anaphylaxis, angioedema, rash/hives)
  • Hematochezia (bloody stools)
  • Rectal hemorrhage

Important Clinical Considerations

Managing Diarrhea

If severe diarrhea develops, patients should stop taking Linzess and contact their physician immediately 1. The key distinction is:

  • Mild-moderate diarrhea: Common and often manageable
  • Severe diarrhea: Requires immediate discontinuation (though uncommon at 4.7% in one study) 5

Dosing and Administration

Take Linzess on an empty stomach at least 30 minutes before the first meal of the day 5, 1. This timing is critical for optimal efficacy.

Long-term Safety

In open-label trials extending up to 18 months, 27% of patients required dose reduction or suspension due to adverse reactions, predominantly diarrhea or other GI effects 1. However, the most common reasons for discontinuation over the first year were actually loss of efficacy and insurance coverage barriers, not adverse events 5.

Special Populations

  • Older adults (≥65 years): No clear differences in outcomes or safety profile, though sample sizes were limited 5
  • Pediatric patients (6-17 years): Diarrhea occurred in 4% (vs. 2% placebo), with similar safety profile 1

Contraindications

Linzess is contraindicated in patients with known or suspected mechanical GI obstruction 5. It should also be avoided in pediatric patients younger than 6 years of age due to risk of serious dehydration.

Red Flag Symptoms

Seek immediate medical attention if you develop 1:

  • Unusual or severe abdominal pain
  • Bright red, bloody stools
  • Black, tar-like stools

These may indicate serious complications requiring emergency evaluation.

Related Questions

I just got linaclotide (Linzess) today; should I start the first dose tomorrow morning before my Saturday travel, or wait until Sunday after the trip to avoid potential side effects such as diarrhea?
What is the minimum age for administering linaclotide (Linzess) for functional constipation and for irritable bowel syndrome with constipation?
In an adult patient with irritable bowel syndrome, how many weeks should linaclotide be started before assessing its efficacy?
In a 25-year-old patient taking linaclotide 145 µg daily who continues to have constipation, should the dose be increased?
What is the best ICD (International Classification of Diseases) code for approval when prescribing Linzess (linaclotide)?
Which selective serotonin reuptake inhibitor is most appropriate for treating anxiety that manifests as rapid speech (psychomotor agitation)?
In septic patients after adequate fluid resuscitation and norepinephrine support, when should dobutamine be started for myocardial depression, and what are the recommended dosing and monitoring parameters?
Is throat clearing and dysphagia common after endotracheal intubation, and what is the typical time course for resolution and when should a specialty referral be considered?
Does menopause cause difficulty maintaining sleep (insomnia of consolidation) and how should it be managed?
What should be included in the management plan for a patient with fatty liver due to metabolic dysfunction (MASH)?
Is the day the embryo is transferred into the uterus considered day 1 of embryonic development?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.